Journal of Pharmacy and Clinical Practice
Vol. 1 No. 3 (2026): Journal of Pharmacy and Clinical Practice

Tantangan Keamanan Terapi ACEi/ARB dan Diuretik dengan AINS: Tinjauan Nefrotoksisitas Triple Whammy, Faktor Risiko Populasi Rawat Jalan dan Manajemen Intervensi Farmasi

Delila Eliza (Program Studi Farmasi, Fakultas Ilmu Kesehatan, UIN Syarif Hidayatullah Jakarta, Banten 15412, Indonesia)
Andi Utari Prasetya Nigrum (Program Studi Farmasi, Universitas Muhammadiyah Makassar, Indonesia)
Suci Ahda Novitri (Program Studi Farmasi, Fakultas Ilmu Kesehatan, UIN Syarif Hidayatullah Jakarta, Banten 15412, Indonesia)
Adha Dastu Illahi (Program Studi Farmasi, Fakultas Ilmu Kesehatan, UIN Syarif Hidayatullah Jakarta, Banten 15412, Indonesia)
Mabrurotul Mustafidah (Program Studi Farmasi, Fakultas Ilmu Kesehatan, UIN Syarif Hidayatullah Jakarta, Banten 15412, Indonesia)



Article Info

Publish Date
26 Aug 2026

Abstract

The combination of Angiotensin-Converting Enzyme Inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB) and diuretics with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) can result in a drug interaction known as the "Triple Whammy". Concomitant use of these three drug classes is a leading cause of preventable iatrogenic Acute Kidney Injury (AKI) in outpatient populations. This narrative review aims to comprehensively outline the hemodynamic pathophysiology of "Triple Whammy" nephrotoxicity, analyze risk factors associated with AKI, and formulate pharmacist intervention management that applicable in primary healthcare settings. Literature review indicates that diuretics induce intravascular volume depletion, ACEi/ARBs abolish the compensatory vasoconstrictive response in efferent arterioles, and NSAIDs inhibit the synthesis of vasodilatory prostaglandins in afferent arterioles. This interaction leads to a failure of renal autoregulation and a drastic reduction in glomerular hydrostatic pressure. Drug combinations, duration of exposure, route of administration, cardiovascular comorbidities, and age are key risk factors for AKI. Preventing AKI requires pharmacist intervention through screening processes, the use of alternative medications, and reinforcement with Continuing Medical Education (CME)

Copyrights © 2026






Journal Info

Abbrev

pharmacy

Publisher

Subject

Description

Journal of Pharmacy and Clinical Practice focuses on the publication of high-quality scientific works related to pharmaceutical sciences and clinical practice. The journal publishes original research articles, review papers, and applied studies that contribute to the advancement of pharmacy practice ...